Search Results
Aug 28, 2026, 11:05 ET 1 MONTH CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Capricor Class Action Lawsuit Before September 28, 2026 Deadline
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, both dates inclusive (the "Class Period"), have until Monday, September 28, 2026 to seek appointment
More news about: Robbins Geller Rudman & Dowd LLP
Aug 27, 2026, 17:33 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CAPR
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Aug 27, 2026, 10:09 ET CAPR DEADLINE: SueWallSt Reminds Capricor Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
Report as one of the top securities litigation firms in the United States.Frequently Asked Questions About the CAPR LawsuitQ: Who are the defendants named in the CAPR lawsuit? A: The complaint names Capricor Therapeutics, Inc. and individual defendants including senior executives
More news about: SueWallSt.com
Aug 27, 2026, 08:00 ET Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit Seeks Recovery for Investors; September 28, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
Did you buy CAPR securities between December 17, 2025 and July 26, 2026?Affected CAPR Investor SummaryWho: Capricor Therapeutics, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Aug 27, 2026, 04:03 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Aug 27, 2026, 04:03 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Aug 26, 2026, 18:54 ET CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
2026 /PRNewswire/ -- National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Following Capricor's recent Q2 2026 earnings release and conference call—notable for an omission of management Q&A with analysts—the company
More news about: Hagens Berman Sobol Shapiro LLP
Aug 26, 2026, 10:09 ET CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
securities litigation firms in the United States.Frequently Asked Questions About the CAPR LawsuitQ: Who is eligible to join the CAPR investor lawsuit? A: Investors who purchased CAPR stock or securities between December 17, 2025 and July 26, 2026 and suffered financial losses
More news about: Levi & Korsinsky, LLP
Aug 25, 2026, 06:24 ET CAPR Investor Losses: Capricor Therapeutics Clinical Data Announcement and Corresponding 64% Stock Drop Trigger Securities Class Action for Investors
Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and certain of the company's senior executives for securities fraud after its significant stock drop resulting from potential violations
More news about: Bleichmar Fonti & Auld LLP
Aug 24, 2026, 19:52 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.So what:
More news about: THE ROSEN LAW FIRM, P. A.
Aug 24, 2026, 16:32 ET Capricor Therapeutics, Inc. Investor Alert - Robbins LLP Reminds CAPR Investors with Significant Losses of the Opportunity to Lead the Class Action Lawsuit Against the Company
securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 (the "Class Period").
More news about: Robbins LLP
Aug 24, 2026, 12:32 ET CAPR Stock Alert: Capricor Therapeutics, Inc. (CAPR) Reports Q2 Earnings Amid Ongoing Securities Class Action Lawsuit - Hagens Berman
2026 /PRNewswire/ -- National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Following Capricor's recent Q2 2026 earnings release and conference call—notable for an omission of management Q&A with analysts—the company
More news about: Hagens Berman Sobol Shapiro LLP
Aug 24, 2026, 09:47 ET CLASS ACTION NOTICE: Berger Montague Advises Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Inquire About a Securities Fraud Class Action
Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through
More news about: Berger Montague
Aug 24, 2026, 02:27 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Aug 24, 2026, 02:21 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Aug 21, 2026, 22:00 ET Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NasdaqGS: CAPR), if they purchased Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). This action is pending in the United
More news about: ClaimsFiler
Aug 21, 2026, 16:15 ET Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
multimedia:https://www.prnewswire.com/news-releases/capricor-therapeutics-inc-capr-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302857016.htmlSOURCE
More news about: Glancy Prongay Wolke & Rotter LLP
Aug 21, 2026, 12:34 ET /C O R R E C T I O N -- Kessler Topaz Meltzer & Check, LLP/
Capricor Therapeutics, Inc. (CAPR) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP Did you buy CAPR securities between December 17, 2025 and July 26, 2026?Affected CAPR Investor Summary
More news about: Kessler Topaz Meltzer & Check, LLP
Aug 21, 2026, 11:15 ET INVESTOR DEADLINE: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Substantial Losses Have Opportunity to Lead Capricor Class Action Lawsuit Before September 28, 2026 Deadline
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, both dates inclusive (the "Class Period"), have until Monday, September 28, 2026 to seek appointment
More news about: Robbins Geller Rudman & Dowd LLP
Aug 21, 2026, 07:45 ET Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders
2026 /PRNewswire/ -- Kaos Capital Ltd. ("Kaos Capital," "we," or "us"), a significant and growing shareholder of Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company"), today issued a letter to fellow shareholders calling on them to support an immediate meeting with the Board of Directors
More news about: KAOS Capital
Aug 21, 2026, 04:33 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Aug 21, 2026, 04:31 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Aug 20, 2026, 13:03 ET CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics Securities Lawsuit - Contact SueWallSt
-- SueWallSt provides context on investor sentiment surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR) and notifies shareholders that a securities class action has been filed on behalf of investors who purchased CAPR securities between December 17, 2025 and July 26, 2026.
More news about: SueWallSt.com
Aug 20, 2026, 13:00 ET Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
action lawsuit against Capricor Therapeutics, Inc. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CAPRICOR THERAPEUTICS, INC. (CAPR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE SEPTEMBER 28, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD
More news about: Law Offices of Howard G. Smith
Aug 20, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CAPR
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP